Skip to main
FOLD
FOLD logo

Amicus Therapeutics (FOLD)

$0.00

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Buy Amicus Therapeutics (FOLD) Stock

About Amicus Therapeutics (FOLD)

Amicus Therapeutics, Inc. is a biotechnology company, which focuses on discovering, developing, and delivering medicines for people living with metabolic diseases. Its product portfolio includes first and only approved oral precision medicine for people living with Fabry disease who have amenable genetic variants, a novel, clinical-stage, treatment paradigm for Pompe disease and a rare disease gen...read more
Market cap$1.86B
Today's volume4.23M
Revenue (TTM)$543.14M
Avg. daily volume4.38M
EBITDA (TTM)$56.02M
Open$6.05
Price / earnings ratio-63.54x
Today's range$6.01 - $6.22
Debt / equity229.11x
52 week range$5.81 - $12.65
5 year debt / equity230.01x
Beta (LTM)0.76x
Interest coverage0.69x
Dividend & yield$0.00 (0.00%)
Current ratio3.34x
Ex-dividend date
Next earningsAug 7, 2025
Dividend payable date

Amicus Therapeutics Stock Rating

What analysts recommend for FOLD stock, on a scale from 1(buy) to 5(sell).
Buy
Strong Buy 48%
Buy 29%
Hold 19%
Sell 5%
Strong Sell 0%

Frequently Asked Questions (FAQ)

As of Jun 15, 2025, the market cap for FOLD stock is $1.86B

The current P/E ratio for FOLD stock is -63.54

The 52-week high for FOLD stock is $12.65. The current FOLD stock price $undefined is 100.00% below its 52-week high

The 52-week low for FOLD stock is $5.81. The current FOLD stock price $undefined has increased 100.00% from its 52-week low

No, the FOLD stock does not pay dividends to its shareholders

The target price for FOLD stock is $14.83 based on the average of what a group of analyst think FOLD stock could be worth at a future date. This is not a prediction by Public.com

How to buy FOLD stock on Public

  1. 1

    Sign up for a brokerage account on Public

    It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.

  2. 2

    Add funds to your Public account

    There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.

  3. 3

    Choose how much you'd like to invest in FOLD stock

    Navigate to the Explore page. Then, type FOLD into the search bar. When you see FOLD stock appear in the results, tap it to open up the purchase screen.

  4. 4

    Manage your investments in one place

    You can find your newly purchased FOLD stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.

Amicus Therapeutics Stock Earnings

The value each FOLD share was expected to gain vs. the value that each FOLD share actually gained.

Amicus Therapeutics (FOLD) reported Q1 2025 earnings per share (EPS) of $0.03, missing estimates of $0.08 by 62.50%. In the same quarter last year, Amicus Therapeutics's earnings per share (EPS) was -$0.02. Amicus Therapeutics is expected to release next earnings on 08/07/2025, with an earnings per share (EPS) estimate of $0.

Buy Amicus Therapeutics (FOLD) Stock

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.